The role of benzodiazepines in the treatment of catatonia. An evidence-based case study;Benzodiazepinen bij de behandeling van katatonie

Tijdschrift voor Psychiatrie

Volumn 48, Issue 3, 2006, Pages 235-239

  Van Dalfsen, A N ^a,b,f   Van Den Eede, F ^c   Van Den Bossche, B ^a,d   Sabbe, B G C ^c,e  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b GGZ Regio Breda   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Institute for Mental Health   (Netherlands)

^e PC St Norbertushuis te Duffel   (Belgium)

^f PC St Norbertushuis te Duffel ^*  (Belgium)

Author keywords

Benzodiazepine; Catatonia; Substance withdrawal syndrome; Therapy

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CLONAZEPAM; DIAZEPAM; LORAZEPAM; NITRAZEPAM; OXAZEPAM; TEMAZEPAM;

ADULT; ANAMNESIS; CASE REPORT; CATATONIA; FEMALE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; REVIEW; WITHDRAWAL SYNDROME;

EID: 33644959695     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Benazzi, F. (1991). Parenteral clonazepam for catatonia. Canadian Journal of Psychiatry, 36, 312.
2. Bush, G., Fink, M., Petrides, G., e.a. (1996). Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scandinavica, 93, 137-143.
3. Carroll, B.T. (1997). Catatonia due to mixed sedative withdrawal. The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 303-304.
4. Deuschle, M., & Lederbogen, F. (2001). Benzodiazepine withdrawal-induced catatonia. Pharmacopsychiatry, 34, 41-42.
5. Fink, M., & Taylor, M.A. (2003). Catatonia. A Clinician's guide to diagnosis and treatment. New York: Cambridge University Press.
6. Glover, S.G., Escalona, R., Bishop, J., e.a. (1997). Catatonia associated with lorazepam withdrawal. Psychosomatics, 38, 148-150.
7. Hauser, P., Devinsky, O., De Bellis, M., e.a. (1989). Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders. Archives of Neurology, 46, 696-699.
8. Hawkins, J.M., Archer, K.J., Strakowski, S.M., e.a. (1995). Somatic treatment of catatonia. International Journal of Psychiatry in Medicine, 25, 345-369.
9. Kanemoto, K., Miyamoto, T., & Abe, R. (1999). Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure, 8, 364-366.
10. Menza, M.A., & Harris, D. (1989). Benzodiazepines and catatonia: an overview. Biological Psychiatry, 26, 842-846.
11. Northoff, G., Wenke, J., Demisch, L., e.a. (1995). Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology, 122, 182-186.
12. Rosebush, P.I., Hildebrand, A.M., & Mazurek, M.F. (1992). The treatment of catatonia: Benzodiazepines of ECT? American Journal of Psychiatry, 149, 1279-1280.
13. Rosebush, P.I., & Mazurek, M.F. (1996). Catatonia after benzodiazepine withdrawal. Journal of Clinical Psychopharmacology, 16, 315-319.
14. Schmider, J., Standhart, H., Deuschle, M., e.a. (1999). A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biological Psychiatry, 46, 437-441.
15. Ungvari, G.S., Chiu, H.F., Chow, L. Y., e.a. (1999). Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology, 142, 393-398.
16. Ungvari, G.S., Kau, L.S., Wai-Kwong, T., e.a. (2001). The pharmacological treatment of catatonia: an overview. European Archives of Psychiatry and Clinical Neuroscience, 251, 131-134.
17. Ungvari, G.S., Leung, C.M., Wong, M.K., e.a. (1994). Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scandinavica, 89, 285-288.